首页> 外文期刊>Brain research >The selective A(2A) receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat.
【24h】

The selective A(2A) receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat.

机译:选择性A(2A)受体拮抗剂SCH 58261减少了大鼠永久性局灶性局部缺血引起的纹状体递质流出,转弯行为和局部缺血性脑损伤。

获取原文
获取原文并翻译 | 示例
           

摘要

Adenosine A(2A) receptor antagonists have been proved protective in different ischemia models. In this study we verified if the protective effect of the selective A(2A) antagonist, SCH 58261, could be attributed to the reduction of the excitatory amino acid outflow induced by cerebral focal ischemia. A vertical microdialysis probe was inserted into the striatum of male Wistar rats and, after 24 h, permanent right intraluminal middle cerebral artery occlusion (MCAo) was induced. Soon after waking, rats showed a definite contralateral turning behavior, which persisted up to 7 h after MCAo. During 4 h after MCAo, glutamate, aspartate, GABA, adenosine and taurine outflow increased. SCH 58261 (0.01 mg/kg, i.p.), administered 5 min after MCAo, suppressed turning behavior and significantly reduced the outflow of glutamate, aspartate, GABA and adenosine. At 24 h after MCAo, the rats showed severe sensorimotor deficit and damage in both the striatum and cortex. SCH 58261 significantly reduced cortical damage but did not protect against the sensorimotor deficit. The protective effect of SCH 58261 against turning behavior and increased outflow of excitatory amino acids in the first hours after MCAo suggests the potential utility of selective adenosine A(2A) antagonists when administered in the first hours after ischemia. Furthermore, this study, for the first time, proposes that turning behavior after permanent intraluminal MCAo, be used as a precocious index of neurological deficit and neuronal damage.
机译:腺苷A(2A)受体拮抗剂已被证明在不同的缺血模型中具有保护作用。在这项研究中,我们验证了选择性A(2A)拮抗剂SCH 58261的保护作用是否可归因于脑局灶性局部缺血诱导的兴奋性氨基酸外流的减少。将垂直微透析探针插入雄性Wistar大鼠的纹状体中,并在24小时后诱导永久性右腔内大脑中动脉闭塞(MCAo)。醒来后不久,大鼠表现出明确的对侧转弯行为,持续到MCAo后7小时。 MCAo后4小时内,谷氨酸,天冬氨酸,GABA,腺苷和牛磺酸流出增加。 SCH 58261(0.01 mg / kg,腹腔注射)在MCAo后5分钟给药,可抑制转弯行为,并显着减少谷氨酸,天冬氨酸,GABA和腺苷的流出。 MCAo后24小时,大鼠在纹状体和皮质均表现出严重的感觉运动缺陷和损害。 SCH 58261可显着减少皮质损伤,但不能防止感觉运动不足。 SCH 58261在MCAo后的最初几个小时内对转向行为和兴奋性氨基酸流出的保护作用表明,缺血后最初的几个小时内施用选择性腺苷A(2A)拮抗剂具有潜在的实用性。此外,这项研究首次提出将永久性腔内MCAo后的转弯行为用作神经功能缺损和神经元损伤的早熟指标。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号